Information Page
Important notices and rolling announcements
The updates below are intended to keep prospective presenters, delegates, students, speakers, partners,
sponsors and exhibitors informed. This page will continue to be revised as programme, venue and participation
information is confirmed.
Programme
September 2026
Scientific programme development is progressing
The ECTMBICS 2027 programme is being developed as a three-day international scientific meeting with keynote
presentations, oral sessions, poster presentations, emerging-researcher participation, clinical and biotechnology
tracks, digital health discussions, industry exchange and professional networking. Session titles and presenter
allocations will be updated as accepted contributions and invited speakers are confirmed.
Speakers
September 2026
Featured speaker invitations and confirmations are ongoing
Keynote and invited-speaker outreach is continuing across translational medicine, biotechnology, clinical research,
pharmaceutical development, precision medicine, digital health, regulatory science and healthcare innovation.
Confirmed speakers will be added to the Featured Speakers and Programme pages as confirmations are completed.
Participation
Rolling
Abstract submission and participant registration pathways are available
Researchers may submit abstracts for oral or poster presentation consideration, while non-presenting delegates
may register without submitting an abstract. Students, early-career researchers, clinicians, academics, industry
professionals, sponsors and exhibitors may also participate through the appropriate conference pathway.
Total participation is intentionally limited to approximately 120 attendees.
Notice
Ongoing
Themes, sessions, and format details may evolve
As the congress develops, themes, session titles, presentation formats, speaker allocations, poster schedules,
partnership activities and publication information may be refined to reflect accepted submissions, speaker availability,
scientific relevance and operational requirements. The official Programme page will carry the latest confirmed structure.
Partnerships
Rolling
Partnership, sponsorship and exhibition enquiries are open
Universities, hospitals, biotechnology and pharmaceutical companies, diagnostics and digital-health organisations,
research-service providers, professional associations, startups and other relevant organisations may enquire about
partnership, sponsorship, exhibition and industry-engagement opportunities for ECTMBICS 2027.
Publication
Ongoing
Publication guidance is available for presenting authors
Authors of accepted conference contributions may review the Publication page for available manuscript,
proceedings or journal-submission guidance. Conference acceptance, registration and presentation do not
guarantee journal publication; all manuscripts remain subject to the relevant editorial and peer-review process.
Venue
To be confirmed
Singapore venue details will be updated soon
ECTMBICS 2027 is scheduled to take place in Singapore from 20–22 January 2027. The final hotel or host venue
details are currently pending confirmation and will be updated on the Host Location page once finalised.
Need clarification on an update?
If you would like the latest information on abstract submission, registration, programme development,
speakers, publication, partnerships, venue progress or visa support for ECTMBICS 2027,
please contact the organising team directly.